Skip to main content

Catalyst Funds Management Pty Ltd

SEC CIK
0001896150
Latest filing
Aug 10, 2026

MLTX holding history

MoonLake Immunotherapeutics in every 13F filed by Catalyst Funds Management Pty Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

MLTX overviewAll 13F holders of MLTXFull Q2 2026 holdings

Shares (Q2 2024)
0
Sold out in Q2 2024
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q1 2024
Holdings of MLTX by Catalyst Funds Management Pty Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20240$00.0%−4,800−100.0%Sold outHolders
Q1 20244,800$241.1K0.1%–No prior filingHolders